Member access

4-Traders Homepage  >  Shares  >  Nyse MKT  >  IGI LABORIGI       

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Engages in the development and commercialization of products for the dermatology market

IGI Laboratories, Inc. develops, manufactures and markets topical formulations.

The company sells generic topical pharmaceutical products under IGI label.

It also provides development, formulation, and manufacturing services to the pharmaceutical, over-the-counter and cosmetic markets.

The company's products are used in a wide range of applications from cosmetics and cosmeceuticals to the prescription treatment of conditions like dermatitis, psoriasis, and eczema.

IGI Laboratories was founded by Jane E. Hager in 1977 and is headquartered in Buena, NJ.

Number of employees : 81 persons.
Sales per Businesses
20122013Delta
USD (in Million)%USD (in Million)%
Topical Formulations8.56100%18.22100% +53.01%
Sales per Regions
20122013Delta
USD (in Million)%USD (in Million)%
United States8.56100%18.22100% +53.01%
Managers
NameAgeSinceTitle
Jason Grenfell-Gardner, MBA402012President, Chief Executive Officer & Director
Joyce Erony552009Chairman
Sanjay Samudre-2013Operations Director
Jenniffer L. Collins, CPA462011Chief Financial Officer & Secretary
Kenneth J. Miller II, PhD-2012Senior Vice President-Research & Development
James C. Gale, MBA652009Independent Director
Narendra N. Borkar742009Independent Director
Bhaskar Chaudhuri, PhD602010Independent Director
Steven Hubrig Koehler MBA, CPA642014Director
John E. Celentano, MBA552015Director
Shareholders
NameShares%
Signet Healthcare Partners LLC 9,851,861 18.7%
Janus Capital Management LLC 5,335,342 10.1%
Amzak Capital Management LLC 4,574,576 8.67%
Stephen J. Morris 3,004,614 5.69%
Pembroke Management Ltd. 2,811,354 5.33%
Allianz Global Investors U.S. LLC 2,144,584 4.06%
BlackRock Fund Advisors 1,309,646 2.48%
Kopp Investment Advisors LLC 1,286,665 2.44%
The Vanguard Group, Inc. 1,189,262 2.25%
Broadfin Capital LLC 974,810 1.85%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Advertisement
Sector Pharmaceuticals
Growth (Revenue) Profitability
JOHNSON & JOHNSON
NOVARTIS AG
ROCHE HOLDING LTD..
PFIZER INC.
MERCK & CO., INC.
SANOFI
ACTAVIS PLC
BAYER AG
NOVO NORDISK A/S
GLAXOSMITHKLINE P..
BRISTOL-MYERS SQU..
ELI LILLY AND CO
VALEANT PHARMACEU..
ABBOTT LABORATORI..
TEVA PHARMACEUTIC..
SHIRE PLC
REGENERON PHARMAC..
TAKEDA PHARMACEUT..
ASTELLAS PHARMA I..
CSL LIMITED
Sector Pharmaceuticals
IGI LABORIGI : Connections
SpePharm AG
Icon Bioscience, Inc.
Impopharma, Inc.
Cedarburg Hauser Pharmaceuticals, Inc.
IGI, Inc. /Companion Pet Products Division/
Fluxion Biosciences, Inc.
Signet Healthcare Partners LLC
YourEncore, Inc.
Alpex Pharma SA
Anteis SA
Sanders Morris Harris Group Private Equity
Frazier Management LLC
Thesan Pharmaceuticals, Inc.
PEAK Surgical, Inc.
Silvergate Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc.
Inspire Pharmaceuticals, Inc.
Latshaw Enterprises, Inc.
Catholic Medical Mission Board, Inc.
Arbor Pharmaceuticals, Inc.
J.J. White, Inc.
Company contact information
IGI Laboratories, Inc.
105 Lincoln Avenue
Buena, NJ 08310

Phone : +1.856.697.1441
Fax : +1.856.697.2259
Web : www.igilabs.com
© 2015 People , Fundamentals and Ownership   
Dynamic quotes  
ON
| OFF